Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10515839 | 1.00 | SLC1A2 (0.47) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL7719386 | 0.88 | MEN1 (0.50) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL7719382 | 0.88 | MEN1 (0.50) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL7719379 | 0.88 | MEN1 (0.50) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL30850131 | 0.88 | SLC1A2 (0.64) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL10430282 | 0.88 | SLC1A2 (0.64) | SLC1A2CHRM2CHRM4CHRM3MEN1 | |
| SCHEMBL27294855 | 0.81 | CYP19A1 (0.35) | SLC1A2CHRM2CHRM4CHRM3 | |
| SCHEMBL28948795 | 0.80 | CHRNB2 (0.40) | SLC1A2CHRM2CHRM4CHRM3KMT2A | |
| SCHEMBL21193559 | 0.79 | CHRM2 (0.41) | SLC1A2CHRM2CHRM4CHRM3CHRNB2 | |
| SCHEMBL22053501 | 0.79 | CHRM2 (0.41) | SLC1A2CHRM2CHRM4CHRM3CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023185811-A1 | NOVEL HETEROCYCLIC COMPOUND | 首药控股(北京)股份有限公司 | 2023-10-05 | — | — | WO | disclosed |